MHC class II molecules in tumour immunology: Prognostic marker and target for immune modulation
Keywords: تبدیل بتا فاکتور رشد; CLIP; HLA-DM; HLA-DO; HLA-DR; Invariant Chain; MHC class II; Tumour antigen presentation; Tumour immunology; Vaccination; APC; antigen presenting cell; CLIP; class II-associated invariant chain peptide; CTL; cytotoxic T lymphocyte; EBV; Epstein-Barr vir